photo of Jonathan Melquist, MD, Chief, Section of Urologic Oncology

Jonathan Melquist, MD

Chief, Section of Urologic Oncology

4.9 out of 5 stars 4.9 (1007)

Areas of Expertise Include:

  • Adrenal Masses
  • Bladder Cancer
  • Kidney Cancer
  • Penile and Prostate Cancer
  • Testicular Cancer
  • Hematuria
  • Elevated PSA

Jonathan Melquist, MD, has extensive training in surgical and clinical management of a wide spectrum of urologic problems. He applies his education and research from MD Anderson Cancer Center in Houston to provide advanced care for bladder, kidney, prostate, testicular, and adrenal cancers, and has broad experience in treating general urologic conditions. His areas of expertise include:

About Me

I am a native Midwesterner who quickly fell in love with North Florida. Prior to relocating to Jacksonville, I spent my initial career as a clinical associate in Tallahassee and as a clinical assistant professor at Florida State University. My wife and I and our four kids enjoy biking and sail kayaking and other outdoor adventures that the area has to offer.

There is no greater honor than guiding a patient through the often-complex realm of medicine. With each passing day, our wealth of knowledge of the human body and its ailments expands. Charting the best management course for a patient can be challenging, and my goal as the physician is to advise and advocate for them.


  • Chief, Section of Urologic Oncology


  • Urology
  • Urological Oncology


  • Bachelor of Science - Undergraduate

    Purdue University - West Lafayette, IN

    1998 - 2002

  • Doctor of Medicine - Medical School

    University of Minnesota - Minneapolis, MN

    2002 - 2007

  • Doctor of Medicine - Residency

    State Univeristy of New York - Syracuse, NY

    2012 - 2013

  • Doctor of Medicine - Fellowship

    University of Texas MD Anderson Cancer Center - Houston, TX

    2013 - 2015

Hospital Affiliation

  • Baptist Medical Center Jacksonville

Legal Practice Name

Baptist MD Anderson Cancer Physicians, Inc.